Hawkins (NASDAQ:HWKN – Get Free Report) issued its earnings results on Wednesday. The specialty chemicals company reported $1.35 EPS for the quarter, missing analysts’ consensus estimates of $1.39 by ($0.04), FiscalAI reports. The company had revenue of $315.68 million during the quarter, compared to analyst estimates of $313.42 million. Hawkins had a net margin of 7.53% and a return on equity of 16.08%.
Here are the key takeaways from Hawkins’ conference call:
- Record operating cash flow in Fiscal 2026 funded $167 million in acquisitions, $58 million in capital investments, and $16 million in dividends, while management said the company’s financial condition remains very strong.
- Hawkins expanded its operating scale to nearly 2.5 billion pounds of products moved, 66 locations across 28 states, more than 400 delivery trucks, and nearly 1,200 employees serving customers in 48 states.
- Management plans to continue investing in new Water Treatment Group branches and higher-margin businesses, while maintaining a prudent approach to capital expenditures and acquisitions.
- All eight director nominees were elected, and shareholders approved the ratification of Deloitte & Touche as auditor and the advisory vote on executive compensation; no shareholder questions were submitted.
Hawkins Price Performance
Shares of NASDAQ HWKN traded down $4.42 during mid-day trading on Wednesday, reaching $138.60. 135,392 shares of the company traded hands, compared to its average volume of 164,517. Hawkins has a fifty-two week low of $117.98 and a fifty-two week high of $186.15. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.21 and a quick ratio of 1.46. The firm has a market cap of $2.90 billion, a PE ratio of 35.45, a price-to-earnings-growth ratio of 2.53 and a beta of 0.78. The stock has a fifty day simple moving average of $149.83 and a 200-day simple moving average of $150.40.
Hawkins Dividend Announcement
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on HWKN. Weiss Ratings downgraded Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, July 14th. Barclays set a $170.00 target price on Hawkins and gave the company an “equal weight” rating in a research note on Tuesday, June 30th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $185.00.
Check Out Our Latest Report on Hawkins
Institutional Investors Weigh In On Hawkins
Several hedge funds and other institutional investors have recently bought and sold shares of HWKN. AQR Capital Management LLC grew its stake in shares of Hawkins by 9.0% in the 1st quarter. AQR Capital Management LLC now owns 12,331 shares of the specialty chemicals company’s stock worth $1,306,000 after purchasing an additional 1,017 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Hawkins by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,499 shares of the specialty chemicals company’s stock worth $1,218,000 after buying an additional 494 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Hawkins by 9.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 52,778 shares of the specialty chemicals company’s stock worth $5,590,000 after buying an additional 4,400 shares in the last quarter. Jane Street Group LLC grew its position in Hawkins by 83.2% in the first quarter. Jane Street Group LLC now owns 38,416 shares of the specialty chemicals company’s stock worth $4,069,000 after buying an additional 17,447 shares during the last quarter. Finally, Invesco Ltd. grew its position in Hawkins by 50.3% in the second quarter. Invesco Ltd. now owns 282,349 shares of the specialty chemicals company’s stock worth $40,122,000 after buying an additional 94,503 shares during the last quarter. 69.71% of the stock is currently owned by institutional investors.
About Hawkins
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
Read More
- Five stocks we like better than Hawkins
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
